|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2008-2-11
|
|
pubmed:abstractText |
To investigate the association between magnetic resonance spectroscopic imaging (MRSI)-defined, metabolically abnormal tumor regions and subsequent sites of relapse in data from patients treated with radiotherapy (RT) in a prospective clinical trial.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0360-3016
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
70
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
773-81
|
|
pubmed:meshHeading |
pubmed-meshheading:18262090-Adult,
pubmed-meshheading:18262090-Aspartic Acid,
pubmed-meshheading:18262090-Brain Neoplasms,
pubmed-meshheading:18262090-Choline,
pubmed-meshheading:18262090-Female,
pubmed-meshheading:18262090-Glioblastoma,
pubmed-meshheading:18262090-Humans,
pubmed-meshheading:18262090-Magnetic Resonance Imaging,
pubmed-meshheading:18262090-Magnetic Resonance Spectroscopy,
pubmed-meshheading:18262090-Male,
pubmed-meshheading:18262090-Middle Aged,
pubmed-meshheading:18262090-Neoplasm Recurrence, Local,
pubmed-meshheading:18262090-Predictive Value of Tests,
pubmed-meshheading:18262090-Prospective Studies,
pubmed-meshheading:18262090-Protons
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Proton magnetic resonance spectroscopic imaging in newly diagnosed glioblastoma: predictive value for the site of postradiotherapy relapse in a prospective longitudinal study.
|
|
pubmed:affiliation |
Department of Radiation Oncology, Institut Claudius Regaud, Toulouse, France. Laprie.Anne@claudiusregaud.fr
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial, Phase I
|
